0001209191-24-004208.txt : 20240304
0001209191-24-004208.hdr.sgml : 20240304
20240304160634
ACCESSION NUMBER: 0001209191-24-004208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oakes Gregory
CENTRAL INDEX KEY: 0001809796
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39971
FILM NUMBER: 24714999
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Landos Biopharma, Inc.
CENTRAL INDEX KEY: 0001785345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 815085535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 540-818-2844
MAIL ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-29
0
0001785345
Landos Biopharma, Inc.
LABP
0001809796
Oakes Gregory
C/O LANDOS BIOPHARMA, INC.
PO BOX 11239
BLACKSBURG
VA
24062
1
1
0
0
Chief Executive Officer
0
Restricted Stock Unit
2024-02-29
4
A
0
54454
0.00
A
2034-02-28
Common Stock
54454
54454
D
Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and
shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's
continuous service with the Issuer on each such date.
/s/ Gregory Oakes
2024-03-04